B3
LIVE

Serial Number

99026824

Owner

23Ikigai Pte Ltd.

Attorney

Kathryn A. Gromlovits

Filing Date

Feb 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

B3 Trademark

Serial Number: 99026824

B3 is a trademark filed by 23Ikigai Pte Ltd. on February 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

23Ikigai Pte Ltd. (2 trademarks)

137 Telok Ayer Street, #05-02
Singapore 068602 , SG

Entity Type: 24

Trademark Details

Filing Date

February 3, 2025

Registration Date

Not Registered

Goods & Services

Anti-cancer preparation; Stem cells for medical purposes; Biopharmaceuticals for the treatment of cancer; Reagents for use in medical genetic testing; Preparations for detecting genetic predispositions for medical purposes; Genetic identity tests comprised of reagents for medical purposes; Medical diagnostic reagents and assays for testing of body fluids, none of the aforementioned containing Vitamin B3

Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing cancer screening services; DNA screening for medical purposes; Medical analysis services for the diagnosis of Cancer; Medical services in the field of oncology; Providing a website via a global computer network featuring information in the fields of health, cancer treatment, cancer recovery and survival; Medical services relating to the removal, treatment and processing of stem cells; Genetic Testing for medical purposes

Blood analysis services for scientific research purposes; Stem cell research services; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Research and development services in the field of gene expression systems; Research of induced pluripotent stem cells; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research for medical purposes in the area of cancerous diseases; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 2, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 2, 2025 GNSL
SUSPENSION LETTER WRITTEN
Oct 2, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 3, 2025 MAFR
NEW APPLICATION ENTERED
Feb 3, 2025 NWAP